| Literature DB >> 12898594 |
Kjersti Flatmark1, Kjetil Boye Pedersen, Jahn M Nesland, Heidi Rasmussen, Geir Aamodt, Svein-Ole Mikalsen, Kristin Bjørnland, Øystein Fodstad, Gunhild M Maelandsmo.
Abstract
A large number of experimental studies have linked the S100A4 gene product to the metastatic phenotype of cancer cells and clinical evidence indicates a correlation between S100A4 expression and poor prognosis in several cancer types. The aim of the present study was to analyse the expression of the S100A4 protein in colorectal cancer. Paraffin-embedded samples from 277 colorectal cancer patients were immunostained with anti-S100A4 antibody. Cytoplasmic staining was observed in 178 of 277 samples (64%), whereas, unexpectedly, nuclear expression of S100A4 was found in 88 of 277 of the samples (32%). This novel finding was confirmed by western blot analysis of nuclear fractions isolated from frozen tumour tissue. Statistical analysis revealed a significant correlation between nuclear expression of S100A4 and tumour stage at diagnosis, while there was no such correlation between cytoplasmic staining and tumour stage. The nuclear localization of S100A4 in colorectal cancer and its relationship to tumour stage suggest that this protein may be involved in gene regulatory pathways of relevance to the metastatic phenotype of cancer cells. Copyright 2003 John Wiley & Sons, Ltd.Entities:
Mesh：
Substances：
Year: 2003 PMID： 12898594 DOI： 10.1002/path.1381
Source DB: PubMed Journal: J Pathol ISSN： 0022-3417 Impact factor: 7.996